Medicis Pharmaceutical Corp

Medicis Pharmaceutical — Inamed — Merger or Acquisition (March 2005)

10 slides from Medicis Pharmaceutical's merger presentation, Mar 24, 2005

  1. Slide 1: Medicis and Inamed: creating opportunities together

  2. Slide 2: Our Aspirations

    Our Aspirations Partner of choice for our customers Expanded product portfolio Customer centric focus Patient choice for enhancement of their overall health, beauty and self-esteem Innovative R&D pipeline New, distinct culture, preserving values at the core of each company's success

  3. Slide 3: The Medicis Story

    The Medicis Story Founded 1988 IPO - April 1990 4 stock splits since 1996 NYSE - September 1998 Why the dermatology market? Exceeds $5 billion Driven by 3,200 dermatologists Favorable demographics Evolved with market to aesthetic procedures

  4. Slide 4: Mission Statement

    Mission Statement .. . . helping patients attain a healthy and youthful appearance and self-image

  5. Slide 5: Four-Part Growth Strategy

    Four-Part Growth Strategy Core brand growth Product development Collaborative relationships Strategic acquisitions

  6. Slide 6: Stronger Growth-Oriented Company

    Stronger Growth-Oriented Company Complementary products Enhanced global presence Approximately 1,500 employees Operations in 12 countries Business in over 60 countries Enhanced R&D World class customer service and business support functions Opportunities for advancement within a growing company

  7. Slide 7: Integration Principles (1/2)

    Integration Principles (1/2) Our people are our greatest asset Maintain performance and customer relationships Exercise fiscal responsibility Build best new business model Integration to maximize value Joint task forces to address integration issues

  8. Slide 8: Integration Principles (2/2)

    Great talent from every part of the organization needed to maximize opportunities Move quickly to operate as one business on day merger occurs: One management team One operating plan Business as usual until then Integration Principles (2/2)

  9. Slide 9: Closing Remarks

    Closing Remarks MELCISN <D

  10. Slide 10: Forward-Looking Statements

    FORWARD-LOOKING STATEMENTS This document contains “forward-looking statements” within the meaning of the Securities Litigation Reform Act. All statements included herein that address activities, events or developments that Medicis and Inamed expect, believe or anticipate will or may occur in the fut

Inamed — Merger or Acquisition (March 2005) on 6ix